Список литературы

1. Дедов И.И., Петеркова В.А. Руководство по детской эндокринологии. Москва: Универсум Паблишинг, 2006. 600 p.

2. Charmandari E., Nicolaides N.C., Chrousos G.P. Adrenal insufficiency//The Lancet. 2014. Vol. 383, N 9935. P. 2152 - 2167.

3. Kirkgoz T., Guran T. Primary adrenal insufficiency in children: Diagnosis and management//Best Pract. Res. Clin. Endocrinol. Metab. 2018. Vol. 32, N 4. P. 397 - 424.

4. Park J., Didi M., Blair J. The diagnosis and treatment of adrenal insufficiency during childhood and adolescence//Arch. Dis. Child. 2016. Vol. 101, N 9. P. 860 - 865.

5. Ventura M. et al. The spectrum of pediatric adrenal insufficiency: insights from 34 years of experience//J. Pediatr. Endocrinol. Metab. 2019. Vol. 32, N 7. P. 721 - 726.

6. Oelkers W. Adrenal Insufficiency//N. Engl. J. Med. 1996. Vol. 335, N 16. P. 1206 - 1212.

7. Oelkers W., Diederich S., Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.//J. Clin. Endocrinol. Metab. 1992. Vol. 75, N 1. P. 259 - 264.

8. Jones D.A., Miras A., Tringham J.R. Addison's disease: a diagnostic challenge//Br. J. Hosp. Med. 2008. Vol. 69, N Sup12. P. 192 - 195.

9. Bleicken B. et al. Delayed Diagnosis of Adrenal Insufficiency Is Common: A Cross-Sectional Study in 216 Patients//Am. J. Med. Sci. 2010. Vol. 339, N 6. P. 525 - 531.

10. White P.C., Speiser P.W. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency//Endocr. Rev. 2000. Vol. 21, N 3. P. 245 - 291.

11. Rushworth R.L., Torpy D.J., Falhammar H. Adrenal crises: perspectives and research directions//Endocrine. 2017. Vol. 55, N 2. P. 336 - 345.

12. Bornstein S.R. et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline//J. Clin. Endocrinol. Metab. 2016. Vol. 101, N 2. P. 364 - 389.

13. Chakera A.J., Vaidya B. Addison Disease in Adults: Diagnosis and Management//Am. J. Med. 2010. Vol. 123, N 5. P. 409 - 413.

14. Sarah L T., Jill J., Kelly J. S. Morning Cortisol Levels Affected by Sex and Pubertal Status in Children and Young Adults//J. Clin. Res. Pediatr. Endocrinol. 2013. Vol. 5, N 2. P. 85 - 89.

15. Kazlauskaite R., Maghnie M. Pitfalls in the Diagnosis of Central Adrenal Insufficiency in Children//Endocrine Development/ed. Loche S. et al. S. Karger AG, 2010. Vol. 17. P. 96 - 107.

16. Schmidt I.L. et al. Diagnosis of Adrenal Insufficiency: Evaluation of the Corticotropin-Releasing Hormone Test and Basal Serum Cortisol in Comparison to the Insulin Tolerance Test in Patients with Hypothalamic-Pituitary-Adrenal Disease//J. Clin. Endocrinol. Metab. 2003. Vol. 88, N 9. P. 4193 - 4198.

17. Betterle C. et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies//J. Endocrinol. 1988. Vol. 117, N 3. P. 467 - 475.

18. El-Farhan N. et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays//Clin. Endocrinol. (Oxf.). 2013. Vol. 78, N 5. P. 673 - 680.

19. et al. Pediatric Adrenal Insufficiency: Challenges and Solutions//Ther. Clin. Risk Manag. Informa UK Limited, 2022. Vol. Volume 18. P. 47 - 60.

20. Bowden S.A., Henry R. Pediatric Adrenal Insufficiency: Diagnosis, Management, and New Therapies//Int. J. Pediatr. Hindawi Limited, 2018. Vol. 2018. P. 1 - 8.

21. Pecori Giraldi F. et al. Assessment of ACTH assay variability: a multicenter study//Eur. J. Endocrinol. 2011. Vol. 164, N 4. P. 505 - 512.

22. Van Rijn J.L.M.L. et al. Evaluation of ACTH immunoradiometric assays//Clin. Biochem. 1996. Vol. 29, N 1. P. 93 - 95.

23. Baker P.R. et al. Haplotype Analysis Discriminates Genetic Risk for DR3-Associated Endocrine Autoimmunity and Helps Define Extreme Risk for Addison's Disease//J. Clin. Endocrinol. Metab. 2010. Vol. 95, N 10. P. E263 - E270.

24. , Asplund K., Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency//Clin. Endocrinol. (Oxf.). 1987. Vol. 26, N 2. P. 221 - 226.

25. Jenkins D. et al. Use of ACTH in the diagnosis of adrenal cortical insufficiency//Am. J. Med. 1955. Vol. 18, N 1. P. 3 - 14.

26. Oelkers W. et al. Dose-Response Relationships Between Plasma Adrenocorticotropin (ACTH), Cortisol, Aldosterone, and 18-Hydroxycorticosterone After Injection of ACTH-(1 - 39) or Human Corticotropin-Releasing Hormone in Man*//J. Clin. Endocrinol. Metab. 1988. Vol. 66, N 1. P. 181 - 186.

27. Lee M.K.V. et al. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study//Postgrad. Med. J. 2013. Vol. 89, N 1057. P. 617 - 620.

28. Klose M. et al. Factors Influencing the Adrenocorticotropin Test: Role of Contemporary Cortisol Assays, Body Composition, and Oral Contraceptive Agents//J. Clin. Endocrinol. Metab. 2007. Vol. 92, N 4. P. 1326 - 1333.

29. Magnotti M., Shimshi M. Diagnosing Adrenal Insufficiency: Which Test is Best-The 1 - G or the 250 - G Cosyntropin Stimulation Test?//Endocr. Pract. 2008. Vol. 14, N 2. P. 233 - 238.

30. May M.E., Carey R.M. Rapid adrenocorticotropic hormone test in practice. Retrospective review//Am. J. Med. 1985. Vol. 79, N 6. P. 679 - 684.

31. Oelkers W. The role of high-and low-dose corticotropin tests in the diagnosis of secondary adrenal insufficiency//Eur. J. Endocrinol. 1998. Vol. 139, N 6. P. 567 - 570.

32. Pura M. et al. The low-dose (1 g) Cosyntropin Test (LDT) for Primary Adrenocortical Insufficiency: Defining the Normal Cortisol Response and Report on First Patients with Addison Disease Confirmed with LDT//Exp. Clin. Endocrinol. Diabetes. 2009. Vol. 118, N 03. P. 151 - 157.

33. Kazlauskaite R. et al. Corticotropin Tests for Hypothalamic-Pituitary-Adrenal Insufficiency: A Metaanalysis//J. Clin. Endocrinol. Metab. 2008. Vol. 93, N 11. P. 4245 - 4253.

34. Saenger P. et al. Progressive Adrenal Failure in Polyglandular Autoimmune Disease*//J. Clin. Endocrinol. Metab. 1982. Vol. 54, N 4. P. 863 - 868.

35. Coco G. et al. Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies//J. Clin. Endocrinol. Metab. 2006. Vol. 91, N 5. P. 1637 - 1645.

36. De Bellis A. et al. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.//J. Clin. Endocrinol. Metab. 1993. Vol. 76, N 4. P. 1002 - 1007.

37. Bala N.M. et al. Autoimmune Primary Adrenal Insufficiency in Children//J. Clin. Res. Pediatr. Endocrinol. Galenos Yayinevi, 2022. Vol. 14, N 3. P. 308 - 312.

38. Esposito D., Pasquali D., Johannsson G. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy//J. Clin. Endocrinol. Metab. 2018. Vol. 103, N 2. P. 376 - 387.

39. Conrad K. et al. Autoantibody diagnostics in clinical practice//Autoimmun. Rev. 2012. Vol. 11, N 3. P. 207 - 211.

40. Winqvist O., Karlsson F.A., 21-hydroxylase, a major autoantigen in idiopathic Addison's disease//The Lancet. 1992. Vol. 339, N 8809. P. 1559 - 1562.

41. Laureti S. et al. Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers <1>//J. Clin. Endocrinol. Metab. 1998. Vol. 83, N 9. P. 3163 - 3168.

42. Speiser P.W. et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline//J. Clin. Endocrinol. Metab. 2010. Vol. 95, N 9. P. 4133 - 4160.

43. Bornstein S.R. Predisposing Factors for Adrenal Insufficiency//N. Engl. J. Med. 2009. Vol. 360, N 22. P. 2328 - 2339.

44. Vita J.A. et al. Clinical clues to the cause of Addison's disease//Am. J. Med. 1985. Vol. 78, N 3. P. 461 - 466.

45. Horn M.A. et al. Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease//Clin. Endocrinol. (Oxf.). 2013. Vol. 79, N 3. P. 316 - 320.

46. Laureti S. et al. X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.//J. Clin. Endocrinol. Metab. 1996. Vol. 81, N 2. P. 470 - 474.

47. Nickelsen T., Schulz F., Demisch K. Studies on Cortisol Substitution Therapy in Patients with Adrenal Insufficiency//Exp. Clin. Endocrinol. Diabetes. 2009. Vol. 82, N 04. P. 35 - 41.

48. Czock D. et al. Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids://Clin. Pharmacokinet. 2005. Vol. 44, N 1. P. 61 - 98.

49. Simon N. et al. Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets://Clin. Pharmacokinet. 2010. Vol. 49, N 7. P. 455 - 463.

50. Peacey S.R. et al. Glucocorticoid replacement therapy: are patients over treated and does it matter?//Clin. Endocrinol. (Oxf.). 1997. Vol. 46, N 3. P. 255 - 261.

51. Howlett T.A. An Assessment of Optimal Hydrocortisone Replacement Therapy//Clin. Endocrinol. (Oxf.). 1997. Vol. 46, N 3. P. 263 - 268.

52. Laureti S., Falorni A., Santeusanio F. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses//J. Endocrinol. Invest. 2003. Vol. 26, N 11. P. 1071 - 1075.

53. Barbetta L. et al. Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism//J. Endocrinol. Invest. 2005. Vol. 28, N 9. P. 632 - 637.

54. Ekman B. et al. A randomized, double-blind, crossover study comparing two-and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency//Clin. Endocrinol. (Oxf.). 2012. Vol. 77, N 1. P. 18 - 25.

55. Forss M. et al. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey//BMC Endocr. Disord. 2012. Vol. 12, N 1. P. 8.

56. Bonfig W. et al. Hydrocortisone Dosing during Puberty in Patients with Classical Congenital Adrenal Hyperplasia: An Evidence-Based Recommendation//J. Clin. Endocrinol. Metab. 2009. Vol. 94, N 10. P. 3882 - 3888.

57. Grigorescu-Sido A. et al. Growth Analysis in Patients with 21-Hydroxylase Deficiency Influence of Glucocorticoid Dosage, Age at Diagnosis, Phenotype and Genotype on Growth and Height Outcome//Horm. Res. Paediatr. 2003. Vol. 60, N 2. P. 84 - 90.

58. Purnell J.Q. et al. Association of 24-Hour Cortisol Production Rates, Cortisol-Binding Globulin, and Plasma-Free Cortisol Levels with Body Composition, Leptin Levels, and Aging in Adult Men and Women//J. Clin. Endocrinol. Metab. 2004. Vol. 89, N 1. P. 281 - 287.

59. Plat L. et al. Metabolic Effects of Short-Term Elevations of Plasma Cortisol Are More Pronounced in the Evening Than in the Morning <1>//J. Clin. Endocrinol. Metab. 1999. Vol. 84, N 9. P. 3082 - 3092.

60. Fariss B.L. et al. Comparison of Absorption of Cortisone Acetate and Hydrocortisone Hemisuccinate*//J. Clin. Endocrinol. Metab. 1978. Vol. 47, N 5. P. 1137 - 1140.

61. Filipsson H. et al. The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients//J. Clin. Endocrinol. Metab. 2006. Vol. 91, N 10. P. 3954 - 3961.

62. Wiegand S. et al. Reduced 11-hydroxysteroid dehydrogenase type 1 activity in obese boys//Eur. J. Endocrinol. 2007. Vol. 157, N 3. P. 319 - 324.

63. Williams G.H. et al. Studies of the control of plasma aldosterone concentration in normal man//J. Clin. Invest. 1972. Vol. 51, N 7. P. 1731 - 1742.

64. Fiad T.M. et al. The role of plasma renin activity in evaluating the adequacy of mineralocorticoid replacement in primary adrenal insufficiency//Clin. Endocrinol. (Oxf.). 1996. Vol. 45, N 5. P. 529 - 534.

65. Keilholz U., Guthrie G.P. Case Report: Adverse Effect of Phenytoin on Mineralocorticoid Replacement with Fludrocortisone in Adrenal Insufficiency//Am. J. Med. Sci. 1986. Vol. 291, N 4. P. 280 - 283.

66. Ross I.L. et al. Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients//PLoS ONE/ed. Stover C.M. 2014. Vol. 9, N 3. P. e90768.

67. Inder W.J., Meyer C., Hunt P.J. Management of hypertension and heart failure in patients with Addison's disease//Clin. Endocrinol. (Oxf.). 2015. Vol. 82, N 6. P. 789 - 792.

68. Neumann U. et al. Treatment of congenital adrenal hyperplasia in children aged 0 - 3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure//Eur. J. Endocrinol. Oxford University Press (OUP), 2022. Vol. 186, N 5. P. 587 - 596.

69. Mullis P.E., Hindmarsh P.C., Brook C.G.D. Sodium chloride supplement at diagnosis and during infancy in children with salt-losing 21-hydroxylase deficiency//Eur. J. Pediatr. Springer Science and Business Media LLC, 1990. Vol. 150, N 1. P. 22 - 25.

70. Repping-Wuts H.J.W.J. et al. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis//Eur. J. Endocrinol. 2013. Vol. 169, N 1. P. 17 - 22.

71. Harsch I.A. et al. Cortisone replacement therapy in endocrine disorders - quality of self-care//J. Eval. Clin. Pract. 2010.

72. Braatvedt G.D., Newrick P.G., Corrall R.J. Patients' self administration of hydrocortisone.//BMJ. 1990. Vol. 301, N 6764. P. 1312 - 1312.

73. Fleming L.K., Rapp C.G., Sloane R. Caregiver Knowledge and Self-Confidence of Stress Dosing of Hydrocortisone in Children With Congenital Adrenal Hyperplasia//J. Pediatr. Nurs. 2011. Vol. 26, N 6. P. e55 - e60.

74. Quinkler M. et al. A European Emergency Card for adrenal insufficiency can save lives//Eur. J. Intern. Med. 2015. Vol. 26, N 1. P. 75 - 76.

75. Miller B.S. et al. Emergency Management of Adrenal Insufficiency in Children: Advocating for Treatment Options in Outpatient and Field Settings//J. Investig. Med. SAGE Publications, 2020. Vol. 68, N 1. P. 16 - 25.

76. Bizzarri C. et al. Adrenal crisis in infants and young children with adrenal insufficiency: Management and prevention//Front. Endocrinol. Frontiers Media SA, 2023. Vol. 14.

77. White K., Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event//Eur. J. Endocrinol. 2010. Vol. 162, N 1. P. 115 - 120.

78. On Behalf of Endo ERN (MTG1) et al. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis//Endocrine. Springer Science and Business Media LLC, 2021. Vol. 71, N 3. P. 586 - 594.

79. Woodcock T. et al. Guidelines for the management of glucocorticoids during the peri operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK//Anaesthesia. Wiley, 2020. Vol. 75, N 5. P. 654 - 663.

80. Mushtaq T. et al. Emergency and perioperative management of adrenal insufficiency in children and young people: British Society for Paediatric Endocrinology and Diabetes consensus guidance//Arch. Dis. Child. BMJ, 2023. Vol. 108, N 11. P. 871 - 878.

81. Allolio B. EXTENSIVE EXPERTISE IN ENDOCRINOLOGY: Adrenal crisis//Eur. J. Endocrinol. 2015. Vol. 172, N 3. P. R115 - R124.

82. Hahner S. et al. High Incidence of Adrenal Crisis in Educated Patients With Chronic Adrenal Insufficiency: A Prospective Study//J. Clin. Endocrinol. Metab. 2015. Vol. 100, N 2. P. 407 - 416.

83. Reisch N. et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency//Eur. J. Endocrinol. 2012. Vol. 167, N 1. P. 35 - 42.

84. Fonseca V. et al. Acute adrenal crisis precipitated by thyroxine.//BMJ. 1986. Vol. 292, N 6529. P. 1185 - 1186.

85. Erichsen M.M. et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death//Eur. J. Endocrinol. 2009. Vol. 160, N 2. P. 233 - 237.

86. Husebye E.S., Pearce S.H., Krone N.P., Kampe O. Adrenal insufficiency//Lancet. 2021. Vol. 397, N 10274. P. 613 - 629. УДД 5 УУР C.

87. Дедов И.И., Петеркова В.А.. Справочник детского эндокринолога//3-е изд., испр. и доп. - Москва: Литтерра, 2020. - 496 стр.

88. et al. Primary adrenal insufficiency: case study in 5 tertiary hospitals//An. Pediatr. 2024. Vol. 101, N 5. P. 303 - 309.

89. , . Treatment and Prevention of Adrenal Crisis and Family Education. J Clin Res Pediatr Endocrinol. 2025 Jan 10; 17(Suppl 1): 80 - 92. doi: 10.4274/jcrpe.galenos.2024.2024-6-12-S.

90. Yokoyama K et al. Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine. Jpn J Radiol. 2025 Jun; 43(6): 903 - 926. doi: 10.1007/s11604-025-01732-6.